83.2%
DMARDjuvenile systemic sclerosisMethotrexateMycophenolate mofetiljSScjSSci
…ta. 77% of patients were receiving disease-modifying treatment (DMARD) at enrolment, which increased to 91% at 24 months (p<0.001). P…
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: DMARD ×
DMARD
This treatment is selected. Its supporting articles are shown below.